<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Research Article" dtd-version="1.0"><front><journal-meta><journal-id journal-id-type="pmc">iarjcmb</journal-id><journal-id journal-id-type="pubmed">IARJCMB</journal-id><journal-id journal-id-type="publisher">IARJCMB</journal-id><issn>2789-6005</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.47310/iarjcmb.2025.v05i01.001</article-id><title-group><article-title>The Impact of Psoriasis on Young Iraqi Patients and The Evaluation of Logistic Regression in This Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><given-names>NabeelOmar</given-names><surname>Kadir</surname></name></contrib><xref ref-type="aff" rid="aff-a" /></contrib-group><aff-id id="aff-a">M.B.Ch.B., F.I.C.M.S. (Dermatology and Venereology),Ministry of Higher Education and Scientific Research, Kirkuk University \ College of Medicine, Kirkuk, Iraq.</aff-id><abstract>Background and Aim:Patients' quality of life (QOL) is seriously and adversely affected by psoriasis. In the treatment about psoriasis patients, the connection between improvement in skin lesions and quality of life has recently been recognized. This study was significantly focused on evaluating clinical outcomes of psoriasis's impact on health and quality of life and identifying logistic regression for all young patients' outcomes.Study design:The present study recruited 105 young Iraqi patients of both sexes, aged between 15 and 25 years, and clinical outcomes were recorded during a period starting from January 2023 to January 2024. A series of questionnaires were administered to patients in order to assess psoriasis severity, identify the presence of concomitant skin diseases, and measure anxiety, depression, and quality of life. The following instruments were used: Skindex-29, PLSI, FDLQI, STAI, and WHO QOL.Results: The current findings showed the severity of psoriasis is classified into mild (28.57%), moderate (50.48%), and severe (20.95%). Also, a localized plaque was the most psoriasis-type prevelant, where it got 60% of total young patients. Furthermore, clinical outcomes found psoriasis had no effect (19.05%), a small effect (38.10%), and a moderate effect (28.57%).Conclusions:A psoriasis has a detrimental effect on the young' quality of life, and psychological morbidity may be related to this impairment.</abstract></article-meta></front><body /><back /></article>